Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

The risks of testosterone implants in women outweigh the benefits.

Flutamide reduces hair growth better but has more side effects.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Obesity is linked to higher metabolic syndrome and LH/FSH ratios, but no significant differences exist among PCOS phenotypes.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.